Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.31 CNY 1.71% Market Closed
Market Cap: 8.2B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Jiangsu Kanion Pharmaceutical Co Ltd stock under the Base Case scenario is 25.41 CNY. Compared to the current market price of 14.31 CNY, Jiangsu Kanion Pharmaceutical Co Ltd is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
25.41 CNY
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Jiangsu Kanion Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Jiangsu Kanion Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Jiangsu Kanion Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Jiangsu Kanion Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Jiangsu Kanion Pharmaceutical Co Ltd.

What unique competitive advantages
does Jiangsu Kanion Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Jiangsu Kanion Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide P/S
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide P/E
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide P/OCF
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide P/FCFE
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide P/B
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide EV/S
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide EV/GP
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide EV/EBIT
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide EV/OCF
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide EV/FCFF
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide EV/IC
for Jiangsu Kanion Pharmaceutical Co Ltd.

Show me price targets
for Jiangsu Kanion Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Jiangsu Kanion Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Jiangsu Kanion Pharmaceutical Co Ltd?

What are the Net Income projections
for Jiangsu Kanion Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Jiangsu Kanion Pharmaceutical Co Ltd?

What are the EPS projections
for Jiangsu Kanion Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Jiangsu Kanion Pharmaceutical Co Ltd?

What are the EBIT projections
for Jiangsu Kanion Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Jiangsu Kanion Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Jiangsu Kanion Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Jiangsu Kanion Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Jiangsu Kanion Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Jiangsu Kanion Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Jiangsu Kanion Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Jiangsu Kanion Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Jiangsu Kanion Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide ROE
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide ROA
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide ROIC
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide ROCE
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide Gross Margin
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide Operating Margin
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide Net Margin
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide FCF Margin
for Jiangsu Kanion Pharmaceutical Co Ltd.

Show all solvency ratios
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide D/E Ratio
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide D/A Ratio
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide Quick Ratio
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide Current Ratio
for Jiangsu Kanion Pharmaceutical Co Ltd.

Provide Cash Ratio
for Jiangsu Kanion Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Jiangsu Kanion Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Jiangsu Kanion Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Jiangsu Kanion Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Jiangsu Kanion Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jiangsu Kanion Pharmaceutical Co Ltd

Current Assets 3.9B
Cash & Short-Term Investments 2.3B
Receivables 1B
Other Current Assets 612.1m
Non-Current Assets 3.2B
Long-Term Investments 15.3m
PP&E 2.7B
Intangibles 413.4m
Other Non-Current Assets 60m
Current Liabilities 1.6B
Accounts Payable 230.9m
Accrued Liabilities 1.1B
Other Current Liabilities 277.8m
Non-Current Liabilities 345.4m
Other Non-Current Liabilities 345.4m
Efficiency

Earnings Waterfall
Jiangsu Kanion Pharmaceutical Co Ltd

Revenue
4.6B CNY
Cost of Revenue
-1.3B CNY
Gross Profit
3.3B CNY
Operating Expenses
-2.8B CNY
Operating Income
479.5m CNY
Other Expenses
47m CNY
Net Income
526.4m CNY

Free Cash Flow Analysis
Jiangsu Kanion Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Jiangsu Kanion Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
58/100
Profitability
Score

Jiangsu Kanion Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Jiangsu Kanion Pharmaceutical Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
75/100
Solvency
Score

Jiangsu Kanion Pharmaceutical Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Jiangsu Kanion Pharmaceutical Co Ltd

Wall Street analysts forecast Jiangsu Kanion Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jiangsu Kanion Pharmaceutical Co Ltd is 25.68 CNY with a low forecast of 23.23 CNY and a high forecast of 29.49 CNY.

Lowest
Price Target
23.23 CNY
62% Upside
Average
Price Target
25.68 CNY
79% Upside
Highest
Price Target
29.49 CNY
106% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Jiangsu Kanion Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Jiangsu Kanion Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

8.3B CNY

Dividend Yield

0%

Description

Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacturing and sale of Chinese patent medicine preparations and health products. The company is headquartered in Lianyungang, Jiangsu and currently employs 5,045 full-time employees. The company went IPO on 2002-09-18. The firm provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The firm's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The firm distributes its products mainly within domestic markets.

Contact

JIANGSU
Lianyungang
Jiangning Industrial Park, Economic & Technological Development Zone
+8651885521990
www.kanion.com

IPO

2002-09-18

Employees

5 045

Officers

See Also

Discover More
What is the Intrinsic Value of one Jiangsu Kanion Pharmaceutical Co Ltd stock?

The intrinsic value of one Jiangsu Kanion Pharmaceutical Co Ltd stock under the Base Case scenario is 25.41 CNY.

Is Jiangsu Kanion Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 14.31 CNY, Jiangsu Kanion Pharmaceutical Co Ltd is Undervalued by 44%.

Back to Top